Special Features:
MYGRID SELECTS NETWORK INFERENCE'S CEREBRA
TO DRIVE PROJECT
Life sciences effort breaks new ground with
creation of an "Open Grid Service
Architecture."
e-Science research
project, myGrid, has selected Network Inference as an
industrial partner to
provide its Cerebra Inference Engine to drive the
development of a new open
grid service architecture, producing a virtual
laboratory workbench for the
life sciences community.
The architecture will create a collaborative
and supportive environment that
allows geographically distributed scientists
to implement long-term research
projects using complex distributed
resources.
The Cerebra Inference Engine will enable the grid to
process data based on
semantics, allowing the scientists to identify the
available resources and
services in their field. This will provide for a
dynamic environment where
resources can be exchanged to maintain the integrity
of the workbench as new
resources become available or existing resources
become redundant.
Commenting on the use of the Cerebra Inference
Engine, Professor Carole Goble,
University of Manchester, says: "The Cerebra
Inference Engine's ability to
identify services and organize them into
classifications through very rich
descriptions and to give meaning to these
descriptions is impressive. This
technology means we are able to scale our
solutions and better able to meet
the stringent performance criteria of a
virtual laboratory workbench."
Jon Matonis, CEO, Network Inference,
added: "The myGrid project is a great
opportunity for the life-sciences world
to experience the very real benefits
that Network Inference can bring to this
community. The Cerebra Inference
Engine is ideal for improving the speed and
quality of pharmaceutical and
life-science research including drug discovery,
gene research, and bio-medical
informatics."
The particular focus of
myGrid is on data-intensive e-Science and the
provision of a distributed
environment that supports the in silico
experimental process -- enabling
clients to seamlessly link together databases
and analytical tools using
process flows, extract relevant information from
free texts, and harness
available computational resources for CPU-intensive
tasks.
MyGrid's
industrial collaborators include AstraZeneca, GlaxoSmithKline,
GeneticXchange,
Merck KgaA, SUN Microsystems, IBM, and Epistemics Ltd.
myGrid
The myGrid project is an EPSRC-funded collaboration between the Univ of
Manchester UK, the Univ of Newcastle UK, the Univ of Nottingham UK, the Univ
of Sheffield (UK), the Univ of Southampton UK, IT-Innovation UK, and EMBL
European Bioinformatics Institute.
Industrial collaborators
include:
- AstraZeneca
- GlaxoSmithkline
- GeneticXchange
- Merck KGaA
- SUN Microsystems
- IBM
- Epistemics Ltd and
- Network Inference
Network Inference
Network Inference develops and sells software
that allows applications, across
the extended enterprise, to share data
through semantic integration, providing
a shared frame of reference for
computers to communicate with each other. The
company's Cerebra product
portfolio is based on technology resulting from 13
years of research at
Manchester University. Network Inference is backed by
Nokia Venture Partners
and is based in London, England with a subsidiary in
the US.
http://www.networkinference.com
|
